Physician profile
Jay M Lang
NPI 1659374932
$932.14
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $120 · 2021: $49.02.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $298.15 | 2019-2021 | |
| Amarin Pharma, INC. | $124.85 | 2019 | |
| Preventice Services, LLC | $98.79 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.43 | 2019-2020 | |
| Pfizer INC. | $53.22 | 2019 | |
| Medtronic, INC. | $36.96 | 2021 | |
| Boston Scientific Corporation | $35.39 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.71 | 2019-2020 | |
| Amgen INC. | $30.03 | 2019-2020 | |
| Gilead Sciences, INC. | $28.78 | 2019 | |
| Medtronic Vascular, INC. | $24.90 | 2019 | |
| Abbott Laboratories | $21.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.34 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.23 | 2019 | |
| Biotronik INC. | $13.07 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.49 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.